State Street
INBX

State Street’s Inhibrx, Inc. Common Stock INBX Stock Holding History

State Street’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,417,584
Closed -$84.5M – 4470
2024
Q1 		$84.5M Buy
2,417,584
+781,858
+48% +$28.5M ﹤0.01% 1414
2023
Q4 		$62.2M Buy
1,635,726
+18,955
+1% +$406K ﹤0.01% 1587
2023
Q3 		$29.7M Sell
1,616,771
-200,645
-11% -$4.2M ﹤0.01% 1928
2023
Q2 		$47.2M Sell
1,817,416
-258,574
-12% -$6.04M ﹤0.01% 1707
2023
Q1 		$39.2M Sell
2,075,990
-430,998
-17% -$10M ﹤0.01% 1809
2022
Q4 		$61.8M Buy
2,506,988
+466,934
+23% +$13.7M ﹤0.01% 1491
2022
Q3 		$36.6M Buy
2,040,054
+1,506,986
+283% +$27.2M ﹤0.01% 1815
2022
Q2 		$6.05M Sell
533,068
-1,063,027
-67% -$15.6M ﹤0.01% 3001
2022
Q1 		$35.6M Buy
1,596,095
+686,587
+75% +$17.5M ﹤0.01% 1973
2021
Q4 		$39.7M Buy
909,508
+396,256
+77% +$15.8M ﹤0.01% 1971
2021
Q3 		$17.1M Buy
513,252
+84,025
+20% +$2.56M ﹤0.01% 2581
2021
Q2 		$11.8M Buy
429,227
+269,220
+168% +$5.61M ﹤0.01% 2817
2021
Q1 		$3.21M Buy
160,007
+27,480
+21% +$802K ﹤0.01% 3235
2020
Q4 		$4.37M Buy
+132,527
New +$3.53M ﹤0.01% 3028

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

State Street's INBX Position: Q2 2024 in Review

State Street sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 2,417,584 shares — an estimated $84.5M sold.

State Street first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $84.5M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • State Street reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Street sold 2,417,584 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $84.5M.
  • State Street first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • State Street's Inhibrx, Inc. Common Stock position peaked at $84.5M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.